Chemical inhibitors of LDLRAD4 act through various mechanisms to disrupt the protein's function, which is implicated in processes such as endocytosis and the maintenance of lipid raft integrity. GW4869, as a neutral sphingomyelinase inhibitor, impedes the production of ceramide, a component critical for the structural maintenance of lipid rafts. The disruption of these rafts by GW4869, consequently, can inhibit LDLRAD4 activity that is dependent on intact lipid raft domains. Similarly, Filipin III and Methyl-β-cyclodextrin target the cholesterol-rich lipid rafts by binding to cholesterol and extracting it from the plasma membrane, respectively. Their actions result in compromised raft integrity and, hence, can attenuate the function of LDLRAD4 associated with these microdomains. U18666A also perturbs cholesterol distribution, thereby potentially inhibiting LDLRAD4 by affecting the lipid environments critical for its action.
Dynasore and Monodansylcadaverine focus on the endocytic machinery by inhibiting dynamin and clathrin-mediated endocytosis, respectively. Dynasore's inhibition of the GTPase dynamin ultimately prevents the scission of clathrin-coated vesicles from the plasma membrane, which can inhibit LDLRAD4 function in vesicle trafficking. Monodansylcadaverine similarly inhibits clathrin-mediated endocytosis, affecting LDLRAD4's role in this cellular intake process. Pitstop 2 and Chlorpromazine act by blocking the formation of clathrin-coated pits, with Pitstop 2 directly inhibiting the interaction between clathrin and adaptor proteins, and Chlorpromazine preventing clathrin assembly, both of which can inhibit LDLRAD4's function within these structures. Nystatin's binding to cholesterol disrupts membrane integrity which, like the other lipid raft-targeting inhibitors, can hinder LDLRAD4 activity. Lastly, Genistein's inhibition of tyrosine kinases can affect LDLRAD4 functionality by altering the phosphorylation status of proteins that regulate its activity, thereby inhibiting LDLRAD4's role in cellular signaling pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
GW4869 is a neutral sphingomyelinase (nSMase) inhibitor. LDLRAD4 has been implicated in lipid raft-mediated internalization processes, and as nSMase activity is crucial for maintaining lipid raft integrity by regulating ceramide production, GW4869 can inhibit LDLRAD4 function by disrupting lipid rafts. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a small molecule that inhibits dynamin, a GTPase involved in the scission of clathrin-coated vesicles during endocytosis. As LDLRAD4 is thought to be associated with receptor-mediated endocytosis, inhibition of dynamin by Dynasore can thereby inhibit the function of LDLRAD4 in endocytic pathways. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Pitstop 2 is an inhibitor of clathrin-mediated endocytosis. It acts by blocking the interaction between clathrin and adaptor proteins. LDLRAD4's function is related to its localization in clathrin-coated pits; therefore, Pitstop 2 can inhibit its function by preventing proper clathrin coat assembly. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $118.00 $148.00 | 26 | |
Filipin III is a polyene macrolide that binds to cholesterol, disrupting lipid rafts within the plasma membrane. Considering LDLRAD4's involvement in lipid raft-mediated processes, the disruption of these microdomains by Filipin III can lead to functional inhibition of LDLRAD4. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Methyl-β-cyclodextrin extracts cholesterol from the plasma membrane, disrupting lipid rafts. Through the depletion of cholesterol, this chemical can inhibit LDLRAD4 function by disturbing the lipid environments that are essential for its activity. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is known to inhibit clathrin-mediated endocytosis by preventing the assembly of clathrin-coated pits. As LDLRAD4 operates within these structures, its function can be inhibited by Chlorpromazine through the disruption of clathrin coat formation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. It inhibits the phosphorylation of proteins involved in various signaling pathways. Since LDLRAD4 may be regulated by tyrosine phosphorylation, the inhibition of these kinases by Genistein can lead to the functional inhibition of LDLRAD4. | ||||||
Dansylcadaverine | 10121-91-2 | sc-214851 sc-214851A sc-214851B | 100 mg 250 mg 1 g | $52.00 $89.00 $240.00 | 4 | |
Monodansylcadaverine is a known inhibitor of transglutaminase and is also reported to inhibit clathrin-mediated endocytosis. As LDLRAD4 is involved in endocytosis, the inhibition of this process by Monodansylcadaverine can lead to functional inhibition of LDLRAD4. | ||||||
Nystatin | 1400-61-9 | sc-212431 sc-212431A sc-212431B sc-212431C | 5 MU 25 MU 250 MU 5000 MU | $51.00 $129.00 $251.00 $3570.00 | 7 | |
Nystatin is an antifungal polyene antibiotic that binds to ergosterol in fungal cell membranes and to cholesterol in mammalian cell membranes, disrupting membrane integrity. In mammalian cells, it can disrupt lipid rafts and thus can inhibit the function of LDLRAD4 which is associated with these membrane domains. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride is a diuretic that also acts as an inhibitor of the Na+/H+ exchanger. As ion exchange can influence cellular pH and membrane potential, it may indirectly inhibit LDLRAD4 by altering the cellular conditions necessary for its optimal function. | ||||||